Experienced in Intraventricular Hemorrhage of the Newborn

M K. Kornacka-Borszewska

Katowice, SL, PL 
Experienced in Intraventricular Hemorrhage of the Newborn
Katowice, SL, PL 
OverviewLocationsClinical Research

Overview

M Kornacka-Borszewska practices in Katowice, Poland. Kornacka-Borszewska is rated as an Experienced expert by MediFind in the treatment of Intraventricular Hemorrhage of the Newborn. Their top areas of expertise are Infant Respiratory Distress Syndrome, Premature Infant, Renal Vein Thrombosis, Newborn Transient Tachypnea, and Kidney Transplant.

Their clinical research consists of co-authoring 69 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Intraventricular Hemorrhage of the Newborn.

Locations

Katowice, SL, Poland
Other Locations
Warsaw, MZ 02091, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome
A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: April 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Open-label, Controlled Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
A Multicenter, Randomized, Open-label, Controlled Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
Enrollment Status: Terminated
Publish Date: July 23, 2019
Intervention Type: Combination product, Device
Study Phase: Phase 2
View 1 Less Clinical Trial

69 Total Publications

Author Correction: Exome analysis links kidney malformations to developmental disorders and reveals causal genes.
Author Correction: Exome analysis links kidney malformations to developmental disorders and reveals causal genes.
Journal: Nature communications
Published: October 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kornacka-Borszewska's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile